SEC Company Response from Protara Therapeutics, (TARA) — May 20, 2026
Protara Therapeutics, Inc.
Date: May 20, 2026 · CIK: 0001359931 · Accession: 0001213900-26-059250
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-295862
Letter
Protara Therapeutics, Inc.
345 Park Avenue South, 3rd Floor
New York, NY, 10010
May 20, 2026
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re: Protara Therapeutics, Inc.
Registration Statement on Form S-3
Filing Date May 14, 2026
File No. 333-295862
REQUEST FOR ACCELERATION OF EFFECTIVENESS
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Protara Therapeutics, Inc. (the " Company ") hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (the " Registration Statement "), File No. 333-295862, to 9:30 a.m., Eastern Time, on May 22, 2026, or as soon thereafter as practicable.
Please contact Jennifer Lee of Kirkland & Ellis LLP, counsel to the Company, at (212) 446-4800 as soon as the Registration Statement has been declared effective, or if you have any other questions or concerns regarding this matter.
Sincerely,
/s/ Patrick Fabbio
Show Raw Text
CORRESP 1 filename1.htm Protara Therapeutics, Inc. 345 Park Avenue South, 3rd Floor New York, NY, 10010 May 20, 2026 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: Protara Therapeutics, Inc. Registration Statement on Form S-3 Filing Date May 14, 2026 File No. 333-295862 REQUEST FOR ACCELERATION OF EFFECTIVENESS Pursuant to Rule 461 under the Securities Act of 1933, as amended, Protara Therapeutics, Inc. (the " Company ") hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (the " Registration Statement "), File No. 333-295862, to 9:30 a.m., Eastern Time, on May 22, 2026, or as soon thereafter as practicable. Please contact Jennifer Lee of Kirkland & Ellis LLP, counsel to the Company, at (212) 446-4800 as soon as the Registration Statement has been declared effective, or if you have any other questions or concerns regarding this matter. Sincerely, /s/ Patrick Fabbio Patrick Fabbio Chief Financial Officer